A Brasília hospital cannot approve an Encicarb quotation from the brand name and ampoule price alone. Procurement teams need to confirm the Brazilian-authorised product, elemental iron content, lawful supply route, batch documentation, administration requirements and total treatment cost before selecting an Encicarb injection pharmaceutical injection supplier for Brasilia.
Key takeaways
- Confirm Encicarb is ferric carboxymaltose and compare elemental iron per vial.
- Request batch records, certificate of analysis, and Brazilian import documentation.
- Price administration supplies, trained staff, storage, testing, and wastage—not only vial cost.
- Compare quotations using delivered cost, lead time, shelf life, and replacement terms.
What exactly is being purchased under the Encicarb name?
Encicarb must be identified as ferric carboxymaltose injection, not simply as an iron medicine. A 100 mg/2 mL presentation contains 50 mg of elemental iron per mL; a 10 mL vial may contain 500 mg.
Confirm the approved Encicarb presentation, vial volume, intravenous route and total iron per vial rather than assuming that every “encicarb 100mg 2ml supplier” offers the same pack.
1. State the required specification in the enquiry: ferric carboxymaltose, 100 mg/2 mL, intravenous use, number of ampoules or total elemental iron, and minimum remaining shelf life.
2. Search the exact trade name in ANVISA’s medicines database. Match the Brazilian registration number, registration holder, approved product name, active ingredient, strength, dosage form, manufacturer and manufacturing site. An Indian manufacturer’s ability to export does not establish Brazilian marketing authorisation.
3. Request a scan of the Brazilian-approved carton and Portuguese package insert. Reject an offer that omits the registration holder, batch number, expiry date, storage conditions or traceability information.
4. Before comparing an encicarb injection pharmaceutical injection supplier for brasilia, request the offered batch’s certificate of analysis, batch-release evidence, GMP or manufacturing-licence evidence, and the legal importer or distributor’s details. Confirm that the quotation follows the registered Brazilian presentation, not an unregistered 10 mL or 100 mg/2 mL variant.
Which supplier and import documents should a Brasília hospital require?
Before issuing a purchase order, require proof that the seller can legally supply the exact ferric carboxymaltose presentation to Brasília and that the offered batch is traceable. A search for “encicarb injection supplier brasilia” is only a lead; confirm the generic name, 100 mg/2 mL strength, 50 mg/mL concentration, intravenous route and total elemental iron.
For hospital injection procurement brasilia, request these documents before approval:
- ANVISA registration number, approved Brazilian product name, registration holder, manufacturer and manufacturing site.
- Brazilian distributor or importer licence, manufacturer’s GMP evidence and manufacturing licence.
- Certificate of Analysis for the offered batch, batch number, expiry date, release date and remaining shelf life.
- Certificate of Pharmaceutical Product and batch-release documentation from the responsible quality unit.
- Portuguese package insert, product specification, pharmacovigilance contact and adverse-event reporting route.
- Commercial invoice, packing list, air waybill or bill of lading, import declaration and applicable customs or import-authorisation records.
- Transport qualification, temperature-excursion records and written storage limits from the approved label; do not assume refrigeration is required.
| Supplier route | Evidence before purchase order | Reject or hold when |
|---|---|---|
| Brazilian importer | ANVISA status, import licence and local traceability | No registration holder or importer identified |
| Manufacturer abroad | CPP, GMP records, batch CoA and named Brazilian import route | Quote relies only on a commercial brochure |
| Brazilian distributor | Authorisation from the registration holder and invoice chain | No proof of lawful source |
Put the required presentation, ampoule count, delivery term, shelf life and temperature conditions in the purchase order.
When is ferric carboxymaltose the right formulary choice?
Choose ferric carboxymaltose when iron deficiency needs rapid intravenous replacement, oral iron is ineffective or poorly tolerated, and fewer administration visits justify its acquisition and monitoring requirements.
| Option | Clinical and operational comparison | When it fits the formulary |
|---|---|---|
| Oral iron | Lowest administration cost, but absorption is limited by gastrointestinal effects, adherence and the need for prolonged treatment. | Stable patients who can absorb and tolerate oral therapy and do not need rapid repletion. |
| Ferric carboxymaltose | Intravenous high-dose replacement can reduce visits, but the product-specific maximum dose, dilution, infusion time and hypophosphatemia risk require review. | Patients needing substantial repletion, rapid correction or an alternative after oral treatment fails. |
| Iron sucrose | Intravenous therapy usually requires smaller divided doses, creating more chair time, appointments and administration cost. | Hospitals that accept repeated infusions or need a product whose approved dosing schedule suits their protocol. |
| Ferric derisomaltose | Another intravenous high-dose option, but its concentration, dose limits, preparation instructions, indications and monitoring requirements are not identical. | A valid alternative after clinicians compare the approved label, total treatment visits, safety monitoring and landed cost. |
Do not substitute these products because each is called injectable iron. Compare total elemental iron delivered, not ampoule price, and obtain formulary approval for any product switch. Repeated or high-dose ferric carboxymaltose courses require a phosphate-monitoring plan where clinically indicated.
A search for ferric carboxymaltose injection supplier brasilia should state the generic name, strength, intravenous route, required elemental-iron quantity and delivery terms. Procurement then compares treatment-course cost, nursing time, monitoring and wastage rather than the lowest quoted unit price.
What administration, safety and receiving controls affect the real cost?
Before a dose reaches a patient, verify the approved Portuguese label and package insert: intravenous use only, permitted dilution in 0.9% sodium-chloride solution, dilution volume, use time, storage temperature, light protection, freezing restriction and in-use stability. Do not assume another ferric carboxymaltose presentation follows the same instructions.
For hospital injection procurement in Brasília, receiving and administration controls should include:
- Match the carton, vial or ampoule to the Brazilian-approved product name, registration holder, ANVISA registration number, manufacturer, batch number, expiry date and iron strength per mL.
- Record transport temperature and investigate excursions against the manufacturer’s specified range; do not refrigerate or freeze it unless the approved label says so.
- Confirm trained staff, resuscitation equipment and observation during and after infusion. Anaphylaxis can occur after a previously tolerated dose.
- Prohibit intramuscular and subcutaneous administration, and document the dilution and preparation time.
- Add phosphate monitoring to the protocol for repeated or high-dose courses because hypophosphatemia can become clinically significant.
| Control | Cost prevented | Check before release |
|---|---|---|
| Presentation | Excess units, preparation time and residual waste | Compare 100 mg/2 mL with larger vial options for each usual 500–1,000 mg course |
| Label compliance | Quarantine, treatment delays and regulatory exposure | Reject English- or Spanish-only packs or missing Brazilian traceability data |
| Receiving record | Loss of stock after an unproven excursion | Retain temperature records, batch details and the Portuguese insert |
Compare cost per delivered milligram plus expected wastage, not price per ampoule. A lower unit price can cost more when the pack size forces repeated openings.
How should buyers compare supplier quotations delivered to Brasília?
An encicarb injection supplier brasilia quote is comparable only when every seller prices the same product, quantity and delivery point. State ferric carboxymaltose, 100 mg/2 mL, intravenous use, total elemental iron required, minimum remaining shelf life, and whether the offer is delivered duty paid to Brasília or supplied through a Brazilian importer.
| Offer item | Record in comparison | Cost or service consequence |
|---|---|---|
| Unit price | Price per ampoule and per 100 mg elemental iron | Exposes low-priced quotes based on different presentations |
| Taxes and CMED terms | ICMS, PIS/COFINS, import duty and applicable CMED ceiling | Prevents an export price being compared with a Brazilian hospital price |
| Delivery route | DDP Brasília, importer sale or hospital-managed import | Adds customs, clearance, freight and regulatory responsibility to the correct offer |
| Quantity and shelf life | Ampoules, total iron, batch expiry and minimum remaining shelf life | Reveals stock that will expire before use |
| Documents | ANVISA registration, Brazilian responsible holder, invoice, certificate of analysis and Portuguese package insert | Flags offers that cannot be released for hospital use |
| Service | Lead time, temperature controls, shortage replacement and damaged-goods policy | Prices the operational risk, not just the medicine |
Score each quotation on landed cost, delivery date, document completeness and supplier response time. A quote from NIBA HEALTHCARE belongs on the same sheet as a local distributor’s offer; compare its import route rather than assuming the export price is the hospital’s final cost.
Reject any comparison that omits the delivery point, tax treatment, registration responsibility or batch shelf life. A cheaper ampoule is not cheaper if customs clearance, delayed release or unusable stock falls to the hospital.
Related product
![]() | FERRIC CARBOXYMALTOSE INJECTION Encicarb Injection 10 ml belongs to the group of anti-anaemic medicines used to treat iron deficiency anaemia in patients who are intolerant to oral... View product → |
Frequently asked questions
What exactly is purchased under the Encicarb name?
Encicarb refers to ferric carboxymaltose injection. A 100 mg/2 mL presentation contains 50 mg of elemental iron per mL, while a 10 mL vial may contain 500 mg.
Which documents should a Brasília hospital request from an Encicarb supplier?
Request the commercial invoice, packing list, batch number, certificate of analysis, product specification, manufacturing and expiry dates, transport conditions, and documents showing the product can be legally imported and supplied in Brazil. Confirm current Anvisa requirements with the hospital’s regulatory team.
When is ferric carboxymaltose the right formulary choice?
Compare it with oral iron and other intravenous iron products using the patient’s need for rapid iron replacement, infusion time, dose limits, monitoring requirements, adverse-effect profile, and total treatment cost.
How should buyers compare supplier quotations delivered to Brasília?
Compare the delivered price per milligram of elemental iron, freight and import charges, taxes, minimum order, remaining shelf life, lead time, temperature controls, documentation, insurance, and the supplier’s process for damaged or rejected vials.
